Literature DB >> 2246422

Theophylline poisoning--a review of 64 cases.

M J Parr1, F C Anaes, A C Day, S L Kletchko, P D Crone, A P Rankin.   

Abstract

Sixty-four cases of theophylline poisoning were reviewed. All but two cases represented international self poisoning. The majority of patients were young females who presented acutely after ingestion of sustained release preparations prescribed for asthma. Serum theophylline levels (mean 365 mumol/l, SD 177) indicated a high risk of toxicity. Electrolyte and metabolic abnormalities (hypokalaemia, hypomagnesaemia, hypophosphataemia, hyperglycaemia, acid-base disturbances and leucocytosis) were common. Serum potassium, serum glucose, leucocyte count and length of stay in the intensive care unit all correlated strongly with maximum serum theophylline level (p less than 0.001). The low incidence of life-threatening manifestations of severe toxicity (hypotension, serious arrhythmias or seizures) and excellent outcome, contrasts with many previous reports. The results support the use of a management regimen which emphasizes intensive supportive therapy and restricts the use of charcoal haemoperfusion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2246422     DOI: 10.1007/bf01735178

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  25 in total

1.  Theophylline poisoning in adults.

Authors:  M Helliwell; D Berry
Journal:  Br Med J       Date:  1979-11-03

2.  Effects of size and frequency of oral doses of charcoal on theophylline clearance.

Authors:  G D Park; L Radomski; M J Goldberg; R Spector; G F Johnson; C K Quee
Journal:  Clin Pharmacol Ther       Date:  1983-11       Impact factor: 6.875

3.  Inhibition of theophylline absorption by activated charcoal.

Authors:  C Sintek; L Hendeles; M Weinberger
Journal:  J Pediatr       Date:  1979-02       Impact factor: 4.406

4.  Enhancement of theophylline clearance by oral activated charcoal.

Authors:  W G Berlinger; R Spector; M J Goldberg; G F Johnson; C K Quee; M J Berg
Journal:  Clin Pharmacol Ther       Date:  1983-03       Impact factor: 6.875

5.  Theophylline toxicity and the beta-adrenergic system.

Authors:  T E Kearney; A S Manoguerra; G P Curtis; M G Ziegler
Journal:  Ann Intern Med       Date:  1985-06       Impact factor: 25.391

6.  Metabolic abnormalities associated with intentional theophylline overdose.

Authors:  K W Hall; K E Dobson; J G Dalton; M C Ghignone; S B Penner
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

7.  Life-threatening theophylline toxicity is not predictable by serum levels.

Authors:  M L Aitken; T R Martin
Journal:  Chest       Date:  1987-01       Impact factor: 9.410

Review 8.  Treatment of theophylline intoxication.

Authors:  M J Goldberg; G D Park; W G Berlinger
Journal:  J Allergy Clin Immunol       Date:  1986-10       Impact factor: 10.793

9.  Reassessment of theophylline toxicity. Serum concentrations, clinical course, and treatment.

Authors:  J S Bertino; J W Walker
Journal:  Arch Intern Med       Date:  1987-04

10.  Aminophylline and imidazole as convulsants.

Authors:  W E Stone; M J Javid
Journal:  Arch Int Pharmacodyn Ther       Date:  1980-11
View more
  3 in total

1.  Demographic and Clinical Characteristics of Theophylline Exposures between 1993 and 2011.

Authors:  Nil Hocaoğlu; Engin Yıldıztepe; Başak Bayram; Burç Aydın; Yeşim Tunçok; Şule Kalkan
Journal:  Balkan Med J       Date:  2014-12-01       Impact factor: 2.021

2.  What role for theophylline?

Authors:  J W Jenne
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

3.  Theophylline toxicity causing rhabdomyolysis and acute compartment syndrome.

Authors:  O G Titley; N Williams
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.